ProShares - UltraShort Nasdaq Biotechnology
ETFYour view on BIS
ProShares - UltraShort Nasdaq Biotechnology
ETFProSharesSentiment
AUM (USD)
$2.00M
Expense Ratio
3.2%
Holdings
8
Sentiment
Overview for ProShares - UltraShort Nasdaq Biotechnology
- Fund Type
- ETF
- Fund Issuer
- ProShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- April 7, 2010
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- ProShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- April 7, 2010
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- ProShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- April 7, 2010
- Domicile
- US
About this fund
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index.
BIS Stock Price
Key Facts
EquityExpense Ratio
3.2%
AUM
$2.00M
Fund Details
Expense Ratio
3.2%
Assets Under Management
$2.00M
NAV
$12.09 USD
Holdings
8
Average Volume
8.8K
Inception Date
April 7, 2010
Asset Class
Equity
Fund Issuer
ProShares
Domicile
US
ISIN
US74350P4697
CUSIP
74350P469
NAV Currency
USD
Expense Ratio
3.2%
Assets Under Management
$2.00M
NAV
$12.09 USD
Holdings
8
Average Volume
8.8K
Inception Date
April 7, 2010
Asset Class
Equity
Fund Issuer
ProShares
Domicile
US
ISIN
US74350P4697
CUSIP
74350P469
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.